| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long-Term Potentiation | 8 | 2004 | 99 | 0.930 |
Why?
|
| Glucose | 2 | 2019 | 217 | 0.760 |
Why?
|
| Glucose Transporter Type 1 | 1 | 2019 | 15 | 0.700 |
Why?
|
| Dentate Gyrus | 6 | 2004 | 39 | 0.670 |
Why?
|
| Serotonin | 7 | 1998 | 114 | 0.650 |
Why?
|
| Neurons | 13 | 2019 | 1130 | 0.600 |
Why?
|
| Gaucher Disease | 1 | 2016 | 3 | 0.590 |
Why?
|
| Computer Simulation | 3 | 2014 | 347 | 0.540 |
Why?
|
| Hippocampus | 6 | 2019 | 546 | 0.530 |
Why?
|
| Ethanol | 3 | 2004 | 188 | 0.500 |
Why?
|
| Metabolome | 1 | 2014 | 47 | 0.490 |
Why?
|
| Corticotropin-Releasing Hormone | 8 | 1994 | 47 | 0.470 |
Why?
|
| Thalamic Nuclei | 4 | 1994 | 8 | 0.450 |
Why?
|
| Computational Biology | 1 | 2014 | 275 | 0.420 |
Why?
|
| Rats | 26 | 2010 | 3261 | 0.390 |
Why?
|
| Animals | 42 | 2019 | 14307 | 0.360 |
Why?
|
| Axons | 6 | 1998 | 106 | 0.350 |
Why?
|
| Hypothalamus | 4 | 1998 | 122 | 0.340 |
Why?
|
| Central Nervous System Depressants | 2 | 1999 | 37 | 0.320 |
Why?
|
| Kinetics | 3 | 2019 | 650 | 0.320 |
Why?
|
| Lipid Bilayers | 2 | 2019 | 66 | 0.320 |
Why?
|
| Tyrosine 3-Monooxygenase | 7 | 1995 | 72 | 0.310 |
Why?
|
| Dopamine | 5 | 2007 | 232 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2010 | 1534 | 0.300 |
Why?
|
| Erythrocytes | 2 | 2019 | 107 | 0.280 |
Why?
|
| Propionates | 1 | 2005 | 25 | 0.260 |
Why?
|
| Microwaves | 1 | 2005 | 26 | 0.260 |
Why?
|
| Corpus Striatum | 1 | 2005 | 99 | 0.240 |
Why?
|
| Nucleus Accumbens | 2 | 2010 | 80 | 0.220 |
Why?
|
| Angiotensin II | 3 | 2001 | 92 | 0.220 |
Why?
|
| Catecholamines | 2 | 1994 | 43 | 0.210 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2021 | 9 | 0.210 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2021 | 33 | 0.200 |
Why?
|
| Male | 29 | 2019 | 18870 | 0.200 |
Why?
|
| Brain Chemistry | 2 | 1998 | 134 | 0.200 |
Why?
|
| Sodium Glutamate | 2 | 1990 | 3 | 0.190 |
Why?
|
| Diffusion | 2 | 2019 | 49 | 0.190 |
Why?
|
| Immunohistochemistry | 10 | 1995 | 859 | 0.190 |
Why?
|
| Cerebral Ventricles | 2 | 1990 | 23 | 0.190 |
Why?
|
| Neurons, Afferent | 3 | 1998 | 41 | 0.190 |
Why?
|
| Thermodynamics | 2 | 2018 | 207 | 0.190 |
Why?
|
| Reflex | 1 | 2000 | 31 | 0.190 |
Why?
|
| Postural Balance | 1 | 2000 | 29 | 0.190 |
Why?
|
| Transforming Growth Factor beta | 2 | 2014 | 183 | 0.190 |
Why?
|
| Bicuculline | 1 | 1999 | 14 | 0.180 |
Why?
|
| GABA Antagonists | 1 | 1999 | 25 | 0.180 |
Why?
|
| Cholesterol | 2 | 2011 | 194 | 0.180 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2000 | 131 | 0.180 |
Why?
|
| Biological Transport, Active | 1 | 2019 | 25 | 0.180 |
Why?
|
| Sterol Regulatory Element Binding Protein 2 | 1 | 2019 | 5 | 0.170 |
Why?
|
| Drug Interactions | 2 | 2010 | 137 | 0.170 |
Why?
|
| Glucose Transporter Type 3 | 1 | 2018 | 3 | 0.170 |
Why?
|
| Rats, Inbred Strains | 9 | 1992 | 132 | 0.170 |
Why?
|
| Heart Rate | 1 | 1999 | 248 | 0.160 |
Why?
|
| Temperature | 1 | 2019 | 275 | 0.160 |
Why?
|
| Xylose | 1 | 2017 | 7 | 0.160 |
Why?
|
| Symporters | 1 | 2017 | 11 | 0.160 |
Why?
|
| Spatial Behavior | 2 | 2002 | 22 | 0.150 |
Why?
|
| Microscopy, Electron | 9 | 2013 | 186 | 0.150 |
Why?
|
| Energy Metabolism | 1 | 2018 | 160 | 0.150 |
Why?
|
| Pyrrolidines | 1 | 2016 | 26 | 0.140 |
Why?
|
| Escherichia coli Proteins | 1 | 2017 | 119 | 0.140 |
Why?
|
| Dogs | 1 | 2016 | 138 | 0.140 |
Why?
|
| Apolipoprotein E4 | 2 | 2013 | 47 | 0.140 |
Why?
|
| Humans | 12 | 2021 | 34853 | 0.140 |
Why?
|
| Blood Pressure | 1 | 1999 | 613 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2009 | 68 | 0.130 |
Why?
|
| Nerve Endings | 1 | 1995 | 8 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 1997 | 304 | 0.130 |
Why?
|
| Oxidative Stress | 2 | 2012 | 874 | 0.130 |
Why?
|
| Trehalose | 1 | 2014 | 3 | 0.130 |
Why?
|
| Fibroblasts | 1 | 2016 | 252 | 0.130 |
Why?
|
| Phosphatidylglycerols | 1 | 2014 | 11 | 0.130 |
Why?
|
| Gibberellins | 1 | 2014 | 6 | 0.130 |
Why?
|
| Lateral Ventricles | 1 | 2014 | 8 | 0.130 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 9 | 0.130 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 12 | 0.130 |
Why?
|
| Cocaine | 1 | 1997 | 219 | 0.130 |
Why?
|
| Droughts | 1 | 2014 | 20 | 0.130 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 396 | 0.120 |
Why?
|
| Neocortex | 1 | 2013 | 26 | 0.120 |
Why?
|
| Plant Leaves | 1 | 2014 | 110 | 0.120 |
Why?
|
| Neurogenesis | 1 | 2014 | 55 | 0.120 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 6 | 1998 | 25 | 0.120 |
Why?
|
| Epilepsy | 1 | 2013 | 41 | 0.120 |
Why?
|
| Synapses | 3 | 1994 | 173 | 0.120 |
Why?
|
| Nicotine | 1 | 1996 | 238 | 0.120 |
Why?
|
| Stress, Physiological | 1 | 2014 | 137 | 0.110 |
Why?
|
| Opossums | 2 | 1990 | 11 | 0.110 |
Why?
|
| Histones | 1 | 2014 | 177 | 0.110 |
Why?
|
| Nerve Degeneration | 2 | 1990 | 101 | 0.110 |
Why?
|
| Software | 1 | 2014 | 204 | 0.110 |
Why?
|
| Peritoneum | 2 | 2002 | 8 | 0.110 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 901 | 0.110 |
Why?
|
| Polyesters | 2 | 2002 | 21 | 0.110 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 121 | 0.110 |
Why?
|
| Biogenic Monoamines | 1 | 1992 | 30 | 0.110 |
Why?
|
| Long-Term Synaptic Depression | 1 | 2002 | 8 | 0.110 |
Why?
|
| Protein Isoforms | 2 | 2002 | 121 | 0.110 |
Why?
|
| Time Factors | 3 | 2014 | 1681 | 0.110 |
Why?
|
| Neovascularization, Physiologic | 2 | 2002 | 70 | 0.100 |
Why?
|
| Biocompatible Materials | 2 | 2002 | 75 | 0.100 |
Why?
|
| Dementia, Vascular | 1 | 2012 | 34 | 0.100 |
Why?
|
| Phenotype | 1 | 2014 | 650 | 0.100 |
Why?
|
| Norepinephrine | 3 | 1995 | 107 | 0.100 |
Why?
|
| Central Nervous System Stimulants | 2 | 2010 | 165 | 0.100 |
Why?
|
| Methamphetamine | 2 | 2010 | 155 | 0.100 |
Why?
|
| Conditioning, Operant | 2 | 2010 | 72 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2002 | 135 | 0.100 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 40 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 2 | 2009 | 91 | 0.100 |
Why?
|
| Glutamates | 1 | 1990 | 21 | 0.100 |
Why?
|
| Endothelium, Vascular | 2 | 2002 | 229 | 0.100 |
Why?
|
| Piperidines | 1 | 2010 | 76 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2010 | 80 | 0.090 |
Why?
|
| Memory | 1 | 2002 | 165 | 0.090 |
Why?
|
| Immunoglobulin G | 1 | 1991 | 232 | 0.090 |
Why?
|
| Telencephalon | 1 | 1990 | 14 | 0.090 |
Why?
|
| Neurotoxins | 1 | 1990 | 52 | 0.090 |
Why?
|
| Electric Stimulation | 3 | 2000 | 177 | 0.090 |
Why?
|
| Maze Learning | 2 | 2002 | 100 | 0.090 |
Why?
|
| Macrophages, Peritoneal | 1 | 2009 | 22 | 0.090 |
Why?
|
| Olfactory Bulb | 1 | 1990 | 48 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2019 | 1802 | 0.090 |
Why?
|
| Osteosarcoma | 1 | 2009 | 24 | 0.090 |
Why?
|
| Receptors, LDL | 1 | 2009 | 30 | 0.090 |
Why?
|
| Hypercholesterolemia | 1 | 2009 | 36 | 0.090 |
Why?
|
| Homeostasis | 1 | 2010 | 172 | 0.090 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 42 | 0.090 |
Why?
|
| Astrocytes | 1 | 2010 | 203 | 0.080 |
Why?
|
| Hypothalamic Area, Lateral | 2 | 1999 | 12 | 0.080 |
Why?
|
| Mice | 8 | 2019 | 5668 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2009 | 528 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2009 | 131 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2010 | 184 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2009 | 159 | 0.080 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 600 | 0.080 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2007 | 8 | 0.080 |
Why?
|
| Psychotropic Drugs | 1 | 2007 | 13 | 0.080 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 1994 | 7 | 0.080 |
Why?
|
| Peptide Fragments | 1 | 2009 | 298 | 0.080 |
Why?
|
| Psychomotor Performance | 1 | 2007 | 126 | 0.070 |
Why?
|
| Biphenyl Compounds | 2 | 1997 | 52 | 0.070 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2018 | 117 | 0.070 |
Why?
|
| Tetrazoles | 2 | 1997 | 49 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2004 | 984 | 0.070 |
Why?
|
| Imidazoles | 2 | 1997 | 124 | 0.070 |
Why?
|
| Nuclear Matrix-Associated Proteins | 2 | 2002 | 4 | 0.070 |
Why?
|
| Radiation Tolerance | 1 | 2005 | 12 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2005 | 37 | 0.070 |
Why?
|
| Radiation Dosage | 1 | 2005 | 32 | 0.070 |
Why?
|
| Locus Coeruleus | 1 | 1995 | 15 | 0.070 |
Why?
|
| Nitro Compounds | 1 | 2005 | 32 | 0.060 |
Why?
|
| Acute Disease | 1 | 2005 | 141 | 0.060 |
Why?
|
| Phenylethanolamine N-Methyltransferase | 3 | 1992 | 3 | 0.060 |
Why?
|
| Brain | 2 | 2019 | 1268 | 0.060 |
Why?
|
| Electrophysiology | 2 | 2002 | 130 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2014 | 1442 | 0.060 |
Why?
|
| Urea | 1 | 2004 | 42 | 0.060 |
Why?
|
| Neuropeptides | 1 | 2004 | 57 | 0.060 |
Why?
|
| Losartan | 3 | 2001 | 31 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 2 | 2001 | 75 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2005 | 119 | 0.060 |
Why?
|
| Alzheimer Disease | 3 | 2019 | 881 | 0.060 |
Why?
|
| Female | 7 | 2014 | 19873 | 0.060 |
Why?
|
| Leptin | 1 | 2004 | 115 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2014 | 1426 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2019 | 608 | 0.060 |
Why?
|
| Endothelial Growth Factors | 1 | 2002 | 4 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 608 | 0.060 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2002 | 41 | 0.050 |
Why?
|
| Colchicine | 2 | 1994 | 15 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2021 | 16 | 0.050 |
Why?
|
| Apoptosis | 1 | 2009 | 1317 | 0.050 |
Why?
|
| DNA | 1 | 1995 | 549 | 0.050 |
Why?
|
| Temporomandibular Joint | 1 | 1991 | 3 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2002 | 157 | 0.050 |
Why?
|
| Aorta | 1 | 2002 | 161 | 0.050 |
Why?
|
| Mitochondrial Membranes | 1 | 2021 | 38 | 0.050 |
Why?
|
| Cartilage, Articular | 1 | 1991 | 9 | 0.050 |
Why?
|
| Protein Binding | 2 | 2017 | 913 | 0.050 |
Why?
|
| Proteoglycans | 1 | 1991 | 46 | 0.050 |
Why?
|
| Mitochondrial Proteins | 1 | 2021 | 96 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 592 | 0.050 |
Why?
|
| Perforant Pathway | 1 | 2000 | 15 | 0.050 |
Why?
|
| Injections, Intraperitoneal | 1 | 2000 | 58 | 0.050 |
Why?
|
| Dizocilpine Maleate | 1 | 2000 | 45 | 0.050 |
Why?
|
| Posture | 1 | 2000 | 57 | 0.050 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2000 | 92 | 0.050 |
Why?
|
| Microdialysis | 2 | 2010 | 18 | 0.040 |
Why?
|
| Neural Pathways | 2 | 1997 | 120 | 0.040 |
Why?
|
| Piperazines | 1 | 2000 | 109 | 0.040 |
Why?
|
| Self Administration | 2 | 2010 | 41 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 639 | 0.040 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 1 | 1998 | 4 | 0.040 |
Why?
|
| Papio | 2 | 2013 | 21 | 0.040 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1998 | 6 | 0.040 |
Why?
|
| Preoptic Area | 1 | 1998 | 15 | 0.040 |
Why?
|
| Median Eminence | 1 | 1998 | 10 | 0.040 |
Why?
|
| Peromyscus | 1 | 1998 | 11 | 0.040 |
Why?
|
| Neurosecretory Systems | 1 | 1998 | 13 | 0.040 |
Why?
|
| Prosencephalon | 1 | 1998 | 25 | 0.040 |
Why?
|
| Facilitated Diffusion | 1 | 2018 | 2 | 0.040 |
Why?
|
| Suprachiasmatic Nucleus | 1 | 1998 | 42 | 0.040 |
Why?
|
| Mitochondria | 1 | 2021 | 454 | 0.040 |
Why?
|
| Glucose Transport Proteins, Facilitative | 1 | 2017 | 14 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 2019 | 351 | 0.040 |
Why?
|
| Nuclear Proteins | 1 | 2019 | 287 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 2 | 2010 | 338 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 4 | 1990 | 105 | 0.040 |
Why?
|
| Locomotion | 1 | 1997 | 91 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 1997 | 83 | 0.040 |
Why?
|
| Membrane Potentials | 1 | 1997 | 213 | 0.040 |
Why?
|
| Drug Antagonism | 1 | 1996 | 5 | 0.040 |
Why?
|
| Circadian Rhythm | 1 | 1998 | 212 | 0.040 |
Why?
|
| Herpes Simplex | 1 | 1985 | 16 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 1530 | 0.030 |
Why?
|
| Binding Sites | 1 | 2017 | 597 | 0.030 |
Why?
|
| Integrins | 2 | 2009 | 49 | 0.030 |
Why?
|
| Encephalitis | 1 | 1985 | 39 | 0.030 |
Why?
|
| Microscopy | 1 | 1995 | 32 | 0.030 |
Why?
|
| Papio anubis | 1 | 2014 | 5 | 0.030 |
Why?
|
| Escherichia coli | 1 | 2017 | 436 | 0.030 |
Why?
|
| Nerve Fibers | 2 | 1992 | 36 | 0.030 |
Why?
|
| Tissue Embedding | 1 | 1994 | 2 | 0.030 |
Why?
|
| Apolipoprotein E3 | 1 | 2013 | 10 | 0.030 |
Why?
|
| Tissue Fixation | 1 | 1994 | 18 | 0.030 |
Why?
|
| Injections, Intraventricular | 1 | 1994 | 60 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2014 | 118 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 164 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2013 | 106 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 129 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 1994 | 202 | 0.030 |
Why?
|
| Chromatin | 1 | 2014 | 164 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 1992 | 20 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 164 | 0.030 |
Why?
|
| Receptors, Leptin | 1 | 2002 | 13 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2014 | 198 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 1992 | 100 | 0.030 |
Why?
|
| Injections, Jet | 1 | 1991 | 1 | 0.030 |
Why?
|
| Mice, Nude | 2 | 2002 | 323 | 0.030 |
Why?
|
| Huntington Disease | 1 | 2011 | 25 | 0.020 |
Why?
|
| Biological Transport | 1 | 1991 | 175 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 63 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1990 | 34 | 0.020 |
Why?
|
| Glycine | 1 | 1990 | 44 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2010 | 54 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 9642 | 0.020 |
Why?
|
| Tryptophan | 1 | 1990 | 62 | 0.020 |
Why?
|
| Indicators and Reagents | 1 | 1990 | 57 | 0.020 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2010 | 69 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 19 | 0.020 |
Why?
|
| Streptozocin | 1 | 2009 | 21 | 0.020 |
Why?
|
| Urinalysis | 1 | 2009 | 31 | 0.020 |
Why?
|
| Water | 1 | 2002 | 283 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 75 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2009 | 46 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 57 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 139 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 11034 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2014 | 968 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2002 | 897 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 87 | 0.020 |
Why?
|
| Algorithms | 1 | 2011 | 435 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 550 | 0.020 |
Why?
|
| Olfactory Mucosa | 1 | 1988 | 17 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 407 | 0.020 |
Why?
|
| Dextroamphetamine | 1 | 2007 | 10 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 642 | 0.020 |
Why?
|
| 3,4-Methylenedioxyamphetamine | 1 | 2007 | 1 | 0.020 |
Why?
|
| Toxicology | 1 | 2007 | 7 | 0.020 |
Why?
|
| Rats, Inbred F344 | 1 | 2007 | 228 | 0.020 |
Why?
|
| Calibration | 1 | 2007 | 55 | 0.020 |
Why?
|
| Species Specificity | 1 | 2007 | 233 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2007 | 111 | 0.020 |
Why?
|
| Biotransformation | 1 | 2007 | 65 | 0.020 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2007 | 75 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1988 | 323 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2010 | 486 | 0.020 |
Why?
|
| Texas | 1 | 2008 | 299 | 0.020 |
Why?
|
| Food | 1 | 2007 | 95 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1124 | 0.020 |
Why?
|
| Adrenergic Fibers | 1 | 1986 | 3 | 0.020 |
Why?
|
| Immunochemistry | 1 | 1986 | 9 | 0.020 |
Why?
|
| Rural Population | 1 | 2008 | 253 | 0.020 |
Why?
|
| Mexican Americans | 1 | 2008 | 177 | 0.020 |
Why?
|
| Histocytochemistry | 4 | 1987 | 45 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2010 | 1152 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 1986 | 74 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 528 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 1995 | 111 | 0.020 |
Why?
|
| Naphthyridines | 1 | 2004 | 3 | 0.020 |
Why?
|
| Benzoxazoles | 1 | 2004 | 9 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2009 | 1300 | 0.020 |
Why?
|
| Prevalence | 1 | 2008 | 1425 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2009 | 2128 | 0.010 |
Why?
|
| Culture Media | 1 | 2002 | 84 | 0.010 |
Why?
|
| Receptors, Angiotensin | 1 | 2001 | 11 | 0.010 |
Why?
|
| Perfusion | 1 | 2001 | 31 | 0.010 |
Why?
|
| Keratan Sulfate | 1 | 1991 | 1 | 0.010 |
Why?
|
| Receptors, Fibronectin | 1 | 1991 | 3 | 0.010 |
Why?
|
| Tenascin | 1 | 1991 | 6 | 0.010 |
Why?
|
| Chondroitin Sulfates | 1 | 1991 | 9 | 0.010 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 1991 | 13 | 0.010 |
Why?
|
| Glycosaminoglycans | 1 | 1991 | 22 | 0.010 |
Why?
|
| Hyaluronic Acid | 1 | 1991 | 33 | 0.010 |
Why?
|
| Primates | 1 | 1991 | 36 | 0.010 |
Why?
|
| Laminin | 1 | 1991 | 59 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1991 | 59 | 0.010 |
Why?
|
| Fibronectins | 1 | 1991 | 65 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2001 | 141 | 0.010 |
Why?
|
| Collagen | 1 | 1991 | 162 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3414 | 0.010 |
Why?
|
| Proteins | 1 | 1991 | 352 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 1997 | 109 | 0.010 |
Why?
|
| Simplexvirus | 1 | 1985 | 10 | 0.010 |
Why?
|
| Antigens, Viral | 1 | 1985 | 42 | 0.010 |
Why?
|
| Acetylcholine | 1 | 1985 | 68 | 0.010 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1985 | 70 | 0.010 |
Why?
|
| Olfactory Marker Protein | 1 | 1988 | 1 | 0.010 |
Why?
|
| 3,3'-Diaminobenzidine | 1 | 1986 | 3 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1986 | 135 | 0.000 |
Why?
|
| Saimiri | 1 | 1984 | 6 | 0.000 |
Why?
|
| Supraoptic Nucleus | 1 | 1984 | 5 | 0.000 |
Why?
|
| Gold | 1 | 1986 | 134 | 0.000 |
Why?
|
| Arginine Vasopressin | 1 | 1984 | 13 | 0.000 |
Why?
|
| Tissue Distribution | 1 | 1984 | 197 | 0.000 |
Why?
|